EFTA Document EFTA01457560

I I May 2015 Pharmaceuticals GlaxoSmithKline Newsflow IFiguna 5: Potential newsflow and catalysts Toning Event Etiecnption Mid-IS Competitor Potential approval of LAM/VtABA tiotropium/oladaterol for COPD Nov-15 Avodart US patent expiry 2H16 Brno Headline results from mortality/morbidity study (SUMMIT) 03-Nov-15 R&D Investor day to update on pharmaceutical and vaccine pipelines 4016 Mepolizumab US regulatory decision in severe asthma 2015 Mosquirix EMA approval decision o